Boston Scientific Corporation. and Terumo Corporation. – Notable Participants in embolization coils market
The embolization coils market in nature with good number of players, having considerable revenue in the market. Most of the companies operating in the embolization coils market are offering their products in the North American, European and the Asia Pacific region, whereas, companies have received maximum products approvals from US FDA for the commercialization of their products in the developed and emerging regions.
The most notable market participants are Terumo Corporation, Medtronic, Boston Scientific Corporation, Stryker, DePuy Synthes, Cook, Endoshape, Inc, Balth USA LLC, Penumbra, Inc, and Three Rivers Medical, Inc. occupying a considerable share of the market owing to their offerings to the embolization coils market.
Embolization coils market leaders are involved in activities such as, obtaining approvals to serve a better customer base. For instance, In March, 2018, BALT USA, LLC has received 510(k) clearance for the Optima Coil System and completion of first clinical cases in the United States. The Optima Coil System consists of a state-of-the art coil, a novel pusher and an instantaneous thermal detachment system. Also, during February, 2018, Three Rivers Medical, Inc. received CE Mark (Conformité Européenne) for its Rio Embolization Coil System and has successfully treated its first ten patients.
The embolization coils market has experienced several product approvals for various companies that has resulted into organic growth strategies for the respective companies. However, the embolization coils market has experienced limited numbers of the inorganic strategies. For instance, in September, 2015, Medtronic has acquired Medina Medical. This has helped to expand the embolization device portfolio that are used to treat brain aneurysm.
Below is the list of the product launches done by the operating players in the embolization coils market.
| Year | News | Region |
| 2018 | The company announced it has received 510(k) clearance for the Optima Coil System and completion of first clinical cases in the United States. The Optima Coil System consists of a state-of-the art coil, a novel pusher and an instantaneous thermal detachment system. | North America |
| 2018 | Three Rivers Medical, Inc. announced it has received CE Mark (Conformité Européenne) for its Rio Embolization Coil System and has successfully treated its first ten patients | Europe |
| 2017 | The company announced the United States launch of its Penumbra Occlusion Device (POD) Packing Coil, which is designed to be used as a complementary device with the company’s Ruby and POD embolization products. | North America |
| 2016 | Allurion raised $27 million to support Elipse balloon. The funds have been used to both scale manufacturing and set up clinical trials in the U.S. that could eventually make the product available in America. | North America |
| 2015 | Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimized detachment zone for coils | North America |
